Consistently, CLL samples collected from LN show a strong upregulation of CD73, CD26, ENT1-2, and A2A, which are expressed at significantly higher levels compared to paired PB samples, fostering the idea of a strong ADO signaling in the LN compartment [3]. The gene discussed is ADO; the disease is B-cell chronic lymphocytic leukemia.